Summary

Market Overview

According to DIResearch＇s in-depth investigation and research, the global Parkinson Disease Drug market size will reach 7,168.47 Million USD in 2026 and is projected to reach 11,015.83 Million USD by 2033, with a CAGR of 6.33% (2026-2033). Notably, the China Parkinson Disease Drug market has changed rapidly in the past few years. By 2026, China＇s market size is expected to be Million USD, representing approximately % of the global market share.

Research Summary

Parkinson＇s disease drugs are medications prescribed to individuals diagnosed with Parkinson＇s disease, a neurodegenerative disorder characterized by the progressive loss of dopamine-producing neurons in the brain. These drugs are primarily aimed at alleviating the motor symptoms of the condition, which include tremors, muscle rigidity, and bradykinesia (slowness of movement). The most commonly prescribed class of drugs for Parkinson＇s disease are levodopa medications, which are converted to dopamine in the brain to help replenish the deficient neurotransmitter. Other drug classes, such as dopamine agonists, MAO-B inhibitors, and COMT inhibitors, are also used to manage symptoms and extend the effectiveness of levodopa. While these drugs can provide significant relief from the motor symptoms, they do not cure Parkinson＇s disease, and their use may be tailored to each patient＇s specific needs and stage of the disease.

The major global suppliers of Parkinson Disease Drug include Merck, GSK, Novartis, Boehringer Ingelheim, Teva Pharmaceutical, Abbvie, Kyowa Hakko Kirin Pharma, Astellas Pharma, Desitin Arzneimittel, Endo Pharmaceuticals, Roche, Bausch Health, H.Lundbeck, Supernus Pharmaceuticals, Orion, Stada Arzneimittel, Servier, Recordati, Changzhou Kangpu Pharmaceutical Co., Ltd, CSPC Pharmaceutical Group Limited, Zhejiang Jingxin Pharmaceutical Co., Ltd, Qilu Pharmaceutical, YiChang HEC ChangJiang Pharmaceutical Co., Ltd, ZEIN BIOTECHNOLOGY CO., LTD, Hunan Jiudian Pharmaceutical Co., Ltd, Luye Pharma, Shijiazhuang No.4 Pharmaceutical Co.,Ltd, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Parkinson Disease Drug. Focus on analysing the market share, product portfolio, prices, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Parkinson Disease Drug market. The report data covers historical data from 2021 to 2025, based year in 2026 and forecast data from 2027 to 2033.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Parkinson Disease Drug market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Parkinson Disease Drug industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Suppliers of Parkinson Disease Drug Include:

Merck

GSK

Novartis

Boehringer Ingelheim

Teva Pharmaceutical

Abbvie

Kyowa Hakko Kirin Pharma

Astellas Pharma

Desitin Arzneimittel

Endo Pharmaceuticals

Roche

Bausch Health

H.Lundbeck

Supernus Pharmaceuticals

Orion

Stada Arzneimittel

Servier

Recordati

Changzhou Kangpu Pharmaceutical Co., Ltd

CSPC Pharmaceutical Group Limited

Zhejiang Jingxin Pharmaceutical Co., Ltd

Qilu Pharmaceutical

YiChang HEC ChangJiang Pharmaceutical Co., Ltd

ZEIN BIOTECHNOLOGY CO., LTD

Hunan Jiudian Pharmaceutical Co., Ltd

Luye Pharma

Shijiazhuang No.4 Pharmaceutical Co.,Ltd

Parkinson Disease Drug Product Segment Include:

Sinemet-CR

Trastal

Madopar

COMT Inhibitor

Others

Parkinson Disease Drug Product Application Include:

Under 40 Years Old

40-65 Years Old

Above 65 Years Old




Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Parkinson Disease Drug Industry PESTEL Analysis

Chapter 3: Global Parkinson Disease Drug Industry Porter’s Five Forces Analysis

Chapter 4: Global Parkinson Disease Drug Major Regional Market Size and Forecast Analysis

Chapter 5: Global Parkinson Disease Drug Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Passenger Parkinson Disease Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Parkinson Disease Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Parkinson Disease Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Parkinson Disease Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Parkinson Disease Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Parkinson Disease Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Parkinson Disease Drug Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

ページTOPに戻る

Table of Contents

Table of Contents

1 Parkinson Disease Drug Market Overview

  1.1 Product Definition and Statistical Scope

   1.2 Parkinson Disease Drug Product by Type

       1.2.1 Sinemet-CR

       1.2.2 Trastal

       1.2.3 Madopar

       1.2.4 COMT Inhibitor

       1.2.5 Others

   1.3 Parkinson Disease Drug Product by Application

       1.3.1 Under 40 Years Old

       1.3.2 40-65 Years Old

       1.3.3 Above 65 Years Old

   1.4 Global Parkinson Disease Drug Market Size Analysis (2021-2033)

   1.5 Parkinson Disease Drug Market Development Status and Trends

       1.5.1 Parkinson Disease Drug Industry Development Status Analysis

       1.5.2 Parkinson Disease Drug Industry Development Trends Analysis

2 Parkinson Disease Drug Market PESTEL Analysis

   2.1 Political Factors Analysis

   2.2 Economic Factors Analysis

   2.3 Social Factors Analysis

   2.4 Technological Factors Analysis

   2.5 Environmental Factors Analysis

   2.6 Legal Factors Analysis

3 Parkinson Disease Drug Market Porter's Five Forces Analysis

   3.1 Competitive Rivalry

   3.2 Threat of New Entrants

   3.3 Bargaining Power of Suppliers

   3.4 Bargaining Power of Buyers

   3.5 Threat of Substitutes

4 Global Parkinson Disease Drug Market Analysis by Regions

   4.1 Parkinson Disease Drug Overall Market: 2025 VS 2026 VS 2033

   4.2 Global Parkinson Disease Drug Revenue and Forecast Analysis (2021-2033)

       4.2.1 Global Parkinson Disease Drug Revenue and Market Share by Region (2021-2026)

       4.2.2 Global Parkinson Disease Drug Revenue and Market Share Forecast by Region (2027-2033)

5 Global Parkinson Disease Drug Market Size by Type and Application

   5.1 Global Parkinson Disease Drug Market Size by Type (2021-2033)

   5.2 Global Parkinson Disease Drug Market Size by Application (2021-2033)

6 North America

   6.1 North America Parkinson Disease Drug Market Size and Growth Rate Analysis (2021-2033)

   6.2 North America Key Suppliers Analysis

   6.3 North America Parkinson Disease Drug Market Size by Type

   6.4 North America Parkinson Disease Drug Market Size by Application

   6.5 North America Parkinson Disease Drug Market Size by Country

       6.5.1 US

       6.5.2 Canada

7 Europe

   7.1 Europe Parkinson Disease Drug Market Size and Growth Rate Analysis (2021-2033)

   7.2 Europe Key Suppliers Analysis

   7.3 Europe Parkinson Disease Drug Market Size by Type

   7.4 Europe Parkinson Disease Drug Market Size by Application

   7.5 Europe Parkinson Disease Drug Market Size by Country

       7.5.1 Germany

       7.5.2 France

       7.5.3 United Kingdom

       7.5.4 Italy

       7.5.5 Spain

       7.5.6 Benelux

8 China

   8.1 China Parkinson Disease Drug Market Size and Growth Rate Analysis (2021-2033)

   8.2 China Key Suppliers Analysis

   8.3 China Parkinson Disease Drug Market Size by Type

   8.4 China Parkinson Disease Drug Market Size by Application

9 APAC (excl. China)

   9.1 APAC (excl. China) Parkinson Disease Drug Market Size and Growth Rate Analysis (2021-2033)

   9.2 APAC (excl. China) Key Suppliers Analysis

   9.3 APAC (excl. China) Parkinson Disease Drug Market Size by Type

   9.4 APAC (excl. China) Parkinson Disease Drug Market Size by Application

   9.5 APAC (excl. China) Parkinson Disease Drug Market Size by Country

       9.5.1 Japan

       9.5.2 South Korea

       9.5.3 India

       9.5.4 Australia

       9.5.5 Southeast Asia

10 Latin America

   10.1 Latin America Parkinson Disease Drug Market Size and Growth Rate Analysis (2021-2033)

   10.2 Latin America Key Suppliers Analysis

   10.3 Latin America Parkinson Disease Drug Market Size by Type

   10.4 Latin America Parkinson Disease Drug Market Size by Application

   10.5 Latin America Parkinson Disease Drug Market Size by Country

       10.5.1 Mexico

       10.5.2 Brazil

11 Middle East & Africa

   11.1 Middle East & Africa Parkinson Disease Drug Market Size and Growth Rate Analysis (2021-2033)

   11.2 Middle East & Africa Key Suppliers Analysis

   11.3 Middle East & Africa Parkinson Disease Drug Market Size by Type

   11.4 Middle East & Africa Parkinson Disease Drug Market Size by Application

   11.5 Middle East & Africa Parkinson Disease Drug Market Size by Country

       11.5.1 Saudi Arabia

       11.5.2 South Africa

12 Competition by Suppliers

   12.1 Global Parkinson Disease Drug Market Revenue by Key Suppliers (2021-2033)

   12.2 Parkinson Disease Drug Competitive Landscape Analysis and Market Dynamic

       12.2.1 Parkinson Disease Drug Competitive Landscape Analysis

       12.2.2 Global Key Suppliers Headquarter Location and Key Area Sales

       12.2.3 Market Dynamic

13 Key Companies Analysis

   13.1 Merck

       13.1.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.1.2 Merck Parkinson Disease Drug Product Portfolio

       13.1.3 Merck Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.2 GSK

       13.2.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.2.2 GSK Parkinson Disease Drug Product Portfolio

       13.2.3 GSK Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.3 Novartis

       13.3.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.3.2 Novartis Parkinson Disease Drug Product Portfolio

       13.3.3 Novartis Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.4 Boehringer Ingelheim

       13.4.1 Boehringer Ingelheim Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.4.2 Boehringer Ingelheim Parkinson Disease Drug Product Portfolio

       13.4.3 Boehringer Ingelheim Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.5 Teva Pharmaceutical

       13.5.1 Teva Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.5.2 Teva Pharmaceutical Parkinson Disease Drug Product Portfolio

       13.5.3 Teva Pharmaceutical Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.6 Abbvie

       13.6.1 Abbvie Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.6.2 Abbvie Parkinson Disease Drug Product Portfolio

       13.6.3 Abbvie Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.7 Kyowa Hakko Kirin Pharma

       13.7.1 Kyowa Hakko Kirin Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.7.2 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product Portfolio

       13.7.3 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.8 Astellas Pharma

       13.8.1 Astellas Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.8.2 Astellas Pharma Parkinson Disease Drug Product Portfolio

       13.8.3 Astellas Pharma Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.9 Desitin Arzneimittel

       13.9.1 Desitin Arzneimittel Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.9.2 Desitin Arzneimittel Parkinson Disease Drug Product Portfolio

       13.9.3 Desitin Arzneimittel Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.10 Endo Pharmaceuticals

       13.10.1 Endo Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.10.2 Endo Pharmaceuticals Parkinson Disease Drug Product Portfolio

       13.10.3 Endo Pharmaceuticals Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.11 Roche

       13.11.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.11.2 Roche Parkinson Disease Drug Product Portfolio

       13.11.3 Roche Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.12 Bausch Health

       13.12.1 Bausch Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.12.2 Bausch Health Parkinson Disease Drug Product Portfolio

       13.12.3 Bausch Health Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.13 H.Lundbeck

       13.13.1 H.Lundbeck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.13.2 H.Lundbeck Parkinson Disease Drug Product Portfolio

       13.13.3 H.Lundbeck Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.14 Supernus Pharmaceuticals

       13.14.1 Supernus Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.14.2 Supernus Pharmaceuticals Parkinson Disease Drug Product Portfolio

       13.14.3 Supernus Pharmaceuticals Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.15 Orion

       13.15.1 Orion Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.15.2 Orion Parkinson Disease Drug Product Portfolio

       13.15.3 Orion Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.16 Stada Arzneimittel

       13.16.1 Stada Arzneimittel Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.16.2 Stada Arzneimittel Parkinson Disease Drug Product Portfolio

       13.16.3 Stada Arzneimittel Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.17 Servier

       13.17.1 Servier Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.17.2 Servier Parkinson Disease Drug Product Portfolio

       13.17.3 Servier Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.18 Recordati

       13.18.1 Recordati Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.18.2 Recordati Parkinson Disease Drug Product Portfolio

       13.18.3 Recordati Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.19 Changzhou Kangpu Pharmaceutical Co., Ltd

       13.19.1 Changzhou Kangpu Pharmaceutical Co., Ltd Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.19.2 Changzhou Kangpu Pharmaceutical Co., Ltd Parkinson Disease Drug Product Portfolio

       13.19.3 Changzhou Kangpu Pharmaceutical Co., Ltd Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.20 CSPC Pharmaceutical Group Limited

       13.20.1 CSPC Pharmaceutical Group Limited Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.20.2 CSPC Pharmaceutical Group Limited Parkinson Disease Drug Product Portfolio

       13.20.3 CSPC Pharmaceutical Group Limited Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.21 Zhejiang Jingxin Pharmaceutical Co., Ltd

       13.21.1 Zhejiang Jingxin Pharmaceutical Co., Ltd Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.21.2 Zhejiang Jingxin Pharmaceutical Co., Ltd Parkinson Disease Drug Product Portfolio

       13.21.3 Zhejiang Jingxin Pharmaceutical Co., Ltd Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.22 Qilu Pharmaceutical

       13.22.1 Qilu Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.22.2 Qilu Pharmaceutical Parkinson Disease Drug Product Portfolio

       13.22.3 Qilu Pharmaceutical Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.23 YiChang HEC ChangJiang Pharmaceutical Co., Ltd

       13.23.1 YiChang HEC ChangJiang Pharmaceutical Co., Ltd Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.23.2 YiChang HEC ChangJiang Pharmaceutical Co., Ltd Parkinson Disease Drug Product Portfolio

       13.23.3 YiChang HEC ChangJiang Pharmaceutical Co., Ltd Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.24 ZEIN BIOTECHNOLOGY CO., LTD

       13.24.1 ZEIN BIOTECHNOLOGY CO., LTD Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.24.2 ZEIN BIOTECHNOLOGY CO., LTD Parkinson Disease Drug Product Portfolio

       13.24.3 ZEIN BIOTECHNOLOGY CO., LTD Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.25 Hunan Jiudian Pharmaceutical Co., Ltd

       13.25.1 Hunan Jiudian Pharmaceutical Co., Ltd Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.25.2 Hunan Jiudian Pharmaceutical Co., Ltd Parkinson Disease Drug Product Portfolio

       13.25.3 Hunan Jiudian Pharmaceutical Co., Ltd Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.26 Luye Pharma

       13.26.1 Luye Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.26.2 Luye Pharma Parkinson Disease Drug Product Portfolio

       13.26.3 Luye Pharma Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.27 Shijiazhuang No.4 Pharmaceutical Co.,Ltd

       13.27.1 Shijiazhuang No.4 Pharmaceutical Co.,Ltd Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.27.2 Shijiazhuang No.4 Pharmaceutical Co.,Ltd Parkinson Disease Drug Product Portfolio

       13.27.3 Shijiazhuang No.4 Pharmaceutical Co.,Ltd Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

14 Industry Chain Analysis

   14.1 Parkinson Disease Drug Industry Chain Analysis

   14.2 Parkinson Disease Drug Typical Downstream Customers

   14.3 Parkinson Disease Drug Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

   16.1 Methodology/Research Approach

   16.2 Research Scope

   16.3 Benchmarks and Assumptions

   16.4 Date Source

       16.4.1 Primary Sources

       16.4.2 Secondary Sources

   16.5 Data Cross Validation

   16.6 Disclaimer